CION Ameerpet
If you live with an autoimmune condition, you may have read that it raises your lymphoma risk. Here is the honest, evidence-led picture — how much the risk changes, why chronic inflammation matters, and the warning signs worth knowing.
Lymphoma is a cancer of the lymphocytes — the white blood cells that run the immune system. Because autoimmune diseases involve the immune system attacking the body's own tissues, it makes sense that some of them are linked to lymphoma. And several are: research consistently shows a modest increase in the risk of lymphoma (mostly non-Hodgkin lymphoma) in people with rheumatoid arthritis, systemic lupus, Sjögren's syndrome and coeliac disease.
The single most important thing to hold onto is the difference between relative and absolute risk. Yes, the relative risk is raised — sometimes doubled. But the underlying, everyday risk of lymphoma is low, so even a doubling leaves the absolute risk for any one person small. Most people with these conditions never develop lymphoma. Understanding this autoimmune lymphoma risk properly should replace anxiety with informed, sensible vigilance.
This page explains which conditions carry the link, why chronic inflammation is the main driver, the warning signs worth knowing, and how CION reviews at-risk patients. For the wider context, start with our lymphoma hub, and if you would like a reassurance review, book a free consultation. Other risk factors are covered on related pages such as is lymphoma hereditary?
Of the common autoimmune conditions, Sjögren's syndrome carries the highest lymphoma risk — published series report roughly a 15–20 times higher risk of non-Hodgkin lymphoma, most characteristically MALT lymphoma of the salivary glands. Even so, the great majority of people with Sjögren's never develop lymphoma, which is why specialists focus on watching for specific warning features rather than routine alarm. (Source: patterns reported across published epidemiological series, consistent with NCCN and ESMO lymphoma guidance. Figures vary by individual.)
Not all autoimmune conditions carry the same association. The table below summarises the pattern reported in published research — the figures are broad guides, not personal predictions.
| Condition | Approx. relative risk | Lymphoma type most linked | Main driver |
|---|---|---|---|
| Sjögren's syndrome | Highest (many-fold) | MALT lymphoma (salivary glands) | Chronic gland inflammation |
| Systemic lupus (SLE) | Moderately raised | Diffuse large B-cell lymphoma | Immune activation & disease activity |
| Rheumatoid arthritis | ~2× (severe disease) | Diffuse large B-cell lymphoma | Severity of inflammation |
| Coeliac disease | Raised if uncontrolled | Enteropathy-associated T-cell lymphoma; some B-cell | Ongoing gut inflammation |
Relative risks vary widely between studies and by individual; absolute risk for any one person remains low. This table is a general guide, not a personal estimate. Assessment follows NCCN and ESMO lymphoma guidance.
The common thread across all these conditions is long-standing immune activation — and disease that is well-controlled appears to carry less excess risk than disease that stays active for years.
In autoimmune disease, lymphocytes are kept switched on for years. More activity means more cell division — and each division carries a tiny chance of a DNA copying error that could, over time, lead to lymphoma.
The excess risk clusters in people with the most severe, persistently active disease. This is why bringing inflammation under good control — the goal of your rheumatologist or physician — is likely to be protective, not just symptom-relieving.
The evidence points to the underlying disease, not the treatment, as the main driver. Any risk attributable to a medicine itself appears small next to the effect of the disease. Never stop a prescribed medicine on your own.
Chronic immune stimulation is also why some infections raise lymphoma risk — see EBV & lymphoma and H. pylori & MALT lymphoma. The mechanism is closely related.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Have an autoimmune condition and noticed a swollen node, night sweats or weight loss? Most such symptoms are not lymphoma — but if you are at raised risk, a quick specialist review brings clarity and peace of mind.
If you have an at-risk autoimmune condition, it helps to know which symptoms deserve a mention to your specialist. Most have ordinary causes — infection, the autoimmune disease itself, or nothing serious — but they are worth checking rather than ignoring:
These overlap with the general lymphoma symptoms covered on our lymphoma treatment in Hyderabad page. A symptom that is new, persistent and unexplained is the one to act on. Speak to a CION haematologist if you notice these.
If you are worried, or if a warning sign appears, a clear, stepwise review settles most questions. CION delivers this assessment — and any onward diagnosis and care — directly.
We start by understanding your autoimmune diagnosis, how active it has been, and your symptoms. A careful examination of the lymph nodes and — for Sjögren's syndrome — the salivary glands often provides the most useful information, alongside blood tests that reflect inflammation and blood-cell counts.
If a node or gland is suspicious, imaging and, where appropriate, a lymph-node or tissue biopsy confirm what is going on. A biopsy is the only way to diagnose lymphoma with certainty and to identify its exact type. A bone-marrow examination may be added when indicated. All of these are performed directly by our team.
When lymphoma is confirmed, tissue is tested for markers such as CD20, CD30 and cell-of-origin patterns that guide treatment. These testing concepts help match therapy — described by mechanism and drug class — to the specific lymphoma. Detailed regimens are covered on the lymphoma treatment page rather than here.
Every confirmed case is reviewed by a multidisciplinary tumour board. Chemotherapy, antibody (immunotherapy) treatment, targeted therapy, radiation (IMRT), watch-and-wait monitoring and survivorship care are delivered directly by CION; where a stem-cell transplant or CAR-T cell therapy is needed, we coordinate it through accredited partner facilities.
In coeliac disease, good evidence indicates that a strict, sustained gluten-free diet — by healing the intestinal lining and calming inflammation — reduces the excess lymphoma risk over time. It is a striking example of the wider principle across autoimmune conditions: controlling the underlying inflammation, not just the symptoms, appears to lower the associated risk of lymphoma. (Source: consistent with published gastroenterology and lymphoma epidemiology; individual risk varies.)
You cannot change the fact of having an autoimmune condition, but the evidence suggests several sensible, achievable steps genuinely help — mostly by keeping inflammation in check:
If a previous cancer treatment is part of your history, the separate consideration on our lymphoma after previous cancer treatment page may also be relevant.
It is worth remembering that lymphoma, when it does occur, is among the more treatable cancers. Published series report that Hodgkin lymphoma has a survival of roughly 80–90%, and the most common aggressive non-Hodgkin type, diffuse large B-cell lymphoma, roughly 60–70% — figures that reflect large treated populations and vary considerably by subtype, stage and individual. MALT lymphoma, the type most linked to Sjögren's syndrome, is typically slow-growing and often very manageable.
These outcomes are drawn from published, attributed data consistent with NCCN and ESMO reporting; they are not CION-specific statistics, and no one can promise an individual result. What we can offer is guideline-based, coordinated care and an honest conversation. To meet the team, see our best lymphoma doctors in Hyderabad and best lymphoma hospital in Hyderabad pages.
A second opinion is especially useful in a few situations if you have an autoimmune condition:
CION offers a dedicated, free written second-opinion service. You deserve a plan built around healing, not billing — with transparent costs explained up front. Request your free second opinion or call 18002028726.
Get a free written second opinion from CION's haematology team — especially valuable if you have a persistent swollen node or unexplained symptoms alongside RA, lupus, Sjögren's or coeliac disease.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Some autoimmune conditions are linked to a modestly higher risk of lymphoma, mainly non-Hodgkin lymphoma. The strongest associations are with Sjögren's syndrome, systemic lupus erythematosus (SLE), rheumatoid arthritis and coeliac disease. It is important to keep this in perspective: the relative risk is raised, but the absolute risk for any one person stays low, and most people with these conditions never develop lymphoma. The link appears to be driven largely by long-term immune activation and chronic inflammation rather than the treatment itself. If you have one of these conditions, staying under regular specialist review is the most useful step. For the full picture, see our lymphoma hub.
Lymphoma arises from lymphocytes — the white blood cells at the centre of the immune system. In autoimmune disease, these cells are chronically activated for years as the immune system mistakenly targets the body's own tissues. Constant stimulation means more cell division, and each division carries a small chance of a DNA copying error. Over decades, that persistent proliferation raises the odds that a lymphocyte acquires the genetic changes that lead to lymphoma. The more active and long-standing the inflammation, the higher the associated risk — which is why disease severity, not just diagnosis, matters. Well-controlled disease is thought to carry less excess risk than persistently active disease.
Published series suggest that rheumatoid arthritis is associated with roughly a two-fold increase in the risk of lymphoma compared with the general population, mostly diffuse large B-cell lymphoma. The excess risk is concentrated in people with the most severe, persistently active disease — sustained high inflammation appears to be the main driver. For most people with well-controlled rheumatoid arthritis, the added risk is small. This is one reason rheumatologists aim to bring inflammation under good control. The rheumatoid arthritis lymphoma link is well documented, but it should not cause alarm — it is a reason for steady follow-up, not fear.
Yes. Sjögren's syndrome carries the highest lymphoma risk of the common autoimmune conditions, and it has a characteristic pattern: it is particularly associated with MALT (mucosa-associated lymphoid tissue) lymphoma, especially in the salivary glands. This is a slow-growing (indolent) B-cell lymphoma. Warning features that prompt closer assessment include persistent swelling of the parotid (salivary) glands, new lumps, or certain blood-test changes. Because the sjogren lymphoma link is well recognised, specialists monitor these patients for such signs. A persistent salivary-gland swelling should always be evaluated. Our team can review your imaging and reports — book a free consultation to discuss any concerns.
Coeliac disease is linked to a higher risk of lymphoma, particularly enteropathy-associated T-cell lymphoma (a rare lymphoma of the small bowel) and some B-cell lymphomas. The excess risk is greatest in people with poorly controlled disease or ongoing gut damage. Good evidence indicates that a strict, sustained gluten-free diet — which heals the intestinal lining and calms inflammation — reduces the excess lymphoma risk over time. This fits the wider theme across autoimmune conditions: controlling the underlying inflammation lowers the associated risk. Persistent symptoms despite a strict diet (refractory coeliac disease) warrant specialist assessment. See how prevention and risk reduction fit together on our can lymphoma be prevented? page.
This is a common and understandable worry. Overall, the evidence points to the underlying disease activity and chronic inflammation — not the medicines — as the main driver of the excess lymphoma risk. Untangling the two is difficult, because the people on the strongest treatment usually have the most severe disease. Some immunosuppressive treatments have been examined closely, and any added risk attributable to the drug itself appears small compared with the effect of the disease. Never stop a prescribed medicine on your own: uncontrolled autoimmune disease carries its own serious risks. Discuss the balance with your rheumatologist. For transplant-related immunosuppression specifically, see our post-transplant lymphoma (PTLD) page.
Be alert to the classic lymphoma warning signs, and mention them promptly to your specialist: a lymph node that stays swollen for more than 2–3 weeks without infection, unexplained weight loss, drenching night sweats, persistent fever, or unusual tiredness. For Sjögren's syndrome, add persistent salivary-gland swelling; for coeliac disease, add new or worsening abdominal symptoms despite a strict gluten-free diet. Most of these have ordinary causes and are not lymphoma — but if you have an at-risk autoimmune condition, they are worth checking rather than ignoring. If you are concerned, our haematology team offers a free written second opinion — see lymphoma treatment in Hyderabad or book a consultation.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.